Works matching IS 10538569 AND DT 2024 AND VI 33 AND IP 9
Results: 20
Cover Image, Volume 33, Issue 9.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70038
- Publication type:
- Article
Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70012
- By:
- Publication type:
- Article
Effectiveness of Baricitinib Risk Minimization Activities in Patients With Rheumatoid Arthritis—A Cohort Study in Four Nordic Countries.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70010
- By:
- Publication type:
- Article
Strengthening Real‐World Evidence on Question Not Answered by Randomized Trials: A Trial Calibration Approach.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70008
- By:
- Publication type:
- Article
PMDA Perspective on RWD/RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70007
- By:
- Publication type:
- Article
Association Between Influenza Vaccination and Acute Kidney Injury Among the Elderly: A Self‐Controlled Case Series.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70006
- By:
- Publication type:
- Article
Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non‐melanoma Skin Cancer: An Interrupted Time‐Series Analysis Using Swiss Claims Data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70005
- By:
- Publication type:
- Article
Impact of Regulatory Interventions on Ulipristal Acetate 5 mg (Esmya) Use in Spain: An Interrupted Time‐Series Analysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70004
- By:
- Publication type:
- Article
Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory Action.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70003
- By:
- Publication type:
- Article
Detecting and Dating Early Non‐live Pregnancy Outcomes: Generation of a Novel Pregnancy Algorithm From Norwegian Linked Health Registries.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70002
- By:
- Publication type:
- Article
An Emulated Target Trial Case Study of Real‐World Overall Survival With Second‐Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70001
- By:
- Publication type:
- Article
Potentially Inappropriate Medication Use in Older Adults With Multimorbidity in Taiwan.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70000
- By:
- Publication type:
- Article
Hazard Ratios and Alternative Effect Measures: An Applied Illustration.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.5885
- By:
- Publication type:
- Article
A Two‐Step Framework for Validating Causal Effect Estimates.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.5873
- By:
- Publication type:
- Article
Contemporary Practice and Considerations for Real‐World Data Source Identification and Feasibility Assessment.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.5862
- By:
- Publication type:
- Article
Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming Code.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.5856
- By:
- Publication type:
- Article
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.5849
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.5828
- Publication type:
- Article
Standardization of coding definitions for sickle cell disease complications: A systematic literature review.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.5769
- By:
- Publication type:
- Article
Acarbose might be associated with reduced risk of gastric cancer in patients with diabetes mellitus: A nationwide population‐based cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.5762
- By:
- Publication type:
- Article